BACKGROUND: Recently, a highly specific serum autoantibody was discovered in patients with neuromyelitis optica, called NMO-IgG, and aquaporin-4, the most abundant water channel in the CNS, was identified as the target antigen. Several assays for the detection of NMO-IgG/AQP4-Ab have been described. Tests based on recombinant human AQP4 have been repeatedly demonstrated to be more sensitive than the previous gold standard assay, i.e. immunohistochemistry (IHC) on mouse brain tissue. However, the sophisticated techniques applied restrict their availability to few laboratories worldwide. OBJECTIVE: To develop an easy-to-use, recombinant immunofluorescence assay (rIFA) suitable for standardized and high-throughput detection of NMO-IgG/AQP4-Ab. METHODS: HEK293 cells seeded on cover glasses were transfected with full-length recombinant human AQP4 at large scale. Cover glasses with the immobilized cells were cut into millimetre-sized fragments and transferred to microscopy slides. 151 serum samples from patients with NMO spectrum disorders (NMOSD) and controls were analysed both in the standard IHC assay and in the newly developed rIFA. RESULTS: 25/32 (78.1%) patients with clinically definite NMO and 36/51 (70.6%) of total patients with NMOSD were positive for NMO-IgG/AQP4-Ab in the rIFA compared to 65.6% and 58.8%, respectively, in the IHC assay. CONCLUSION: The recombinant IFA presented here provides laboratories familiar with indirect immunofluorescence microscopy with a highly sensitive and reproducible diagnostic tool for standardized detection of antibodies to AQP4. This new approach could make AQP4-Ab testing, which is of high clinical relevance, more widely available.
MENUMENU
- About NMO
-
-
- NMO FAQsAnswers to some of the most frequently asked questions about NMO, featuring video interviews with leading scientists.
- NMO & Multiple Sclerosis: Did You Know?MS and NMO are treated in different ways and early detection and treatment help ensure best outcomes.
- DiagnosisThe release of new diagnostic criteria for NMO by the International Panel for Neuromyelitis Optica Diagnosis (IPND).
- Recommended ReadingSuggested resources to read from past NMO Patient Day conferences.
-
- Approved TherapeuticsAfter more than 100 years with no approved treatment, today there are three approved therapeutics for NMOSD.
- Clinical Trials in NMOFind access to information, FAQs, and video resources about ongoing clinical trials in Neuromyelitis Optica Spectrum Disorder.
- ResearchBrowse through the results of over $70 million donated to basic and clinical research to solve neuromyelitis optica.
- NMOSD and COVID-19With information changing on a daily basis, we are reaching out to the NMOSD community to aid in your navigation of the many questions at hand.
-
- About Us
-
-
- Foundation EventsCalendar of past and upcoming foundation events, including NMO Roundtable Conference and NMO Patient Days.
- Special ProjectsLearn more about special projects including the ICC, IPND, and the CIRCLES Biorepository.
- CIRCLESCIRCLES is a clinical research study that focuses on better understanding and enabling cures for NMO.
- Industry CouncilThe Guthy-Jackson Charitable Foundation invites all members of industry to join our industry council.
-
- International Clinical ConsortiumThe ICC consists of thought leaders from over 25 countries performing translational research and medicine focused on NMO.
- Medical Advisors and ConsultantsThe medical advisors and consultants to The Guthy-Jackson Charitable Foundation include experts from UCLA, Johns Hopkins, and more.
- PressStay up to date with featured press regarding NMO and The Guthy-Jackson Charitable Foundation.
-
- New to NMO
- Breakthroughs
-
-
- Predict | Clinical BiomarkersThe exciting science of biomarkers and big data analysis is enabling GJCF and its research partners to predict risks, relapses and personalized therapy.
- Protect | Against RelapsesApproved medicines offer a best chance to minimize relapse risks. Now GJCF is driving new treatments to stop relapses in their tracks if they do occur.
-
- Pioneer | Curative TherapiesApproved therapies are a great first step toward preventing relapses. GJCF is now pioneering bold new approaches to cure NMOSD once and for all.
- Promote | Advocacy for AllPatients, caregivers and loved ones are best served with credible information and healthcare access. GJCF promotes wellness via education and advocacy.
-
- Advocacy
-
-
- EventsNMO events are happening all around the world. Browse our listing of advocacy events, educational seminars, and more. Or post your own!
- Patient Advocacy CouncilThe NMO Patient Advocacy Council provides educational resources, extends awareness to urban and rural communities, and connects patients, caregivers, and families in the NMO community.
- NMOStoriesNMOStories exists to provide everyone with a voice, every stakeholder for NMO from patients and caregivers to clinicians and nurses.
-
- Support GroupsNo matter where you are on your NMO journey or how NMO affects your life, support groups aim to offer a sense of comfort and community.
- ContactContact The Guthy-Jackson Charitable Foundation with questions about NMO, advocacy, clinical trials, support, donations, and more.
- My AccountLog in to post events, create donation pages, and get involved in the NMO community.
-
- Research
- Resources
-
-
- 10 Steps Forward10 Steps Forward that may be useful for those newly diagnosed with NMOSD or MOGAD
- NMO Patient Resource GuideOur full-text NMO Patient Resource Guide offers help and information to those who have been affected by NMO.
- VideosExplore our massive library of videos, examining everything from patient care, research, and the work of the foundation.
- Tools for DownloadDownload resources including the NMO Patient Guide, NMO/MS Brochure, Fact Sheets, and more.
-
- Webinars and Breakout SessionsWatch webinars and breakout sessions from the foundation along with our industry and nonprofit partners in the rare disease community.
- Spectrum LibraryBrowse over 1000 research publications related to neuromyelitis optica, including some of the groundbreaking research sponsored by the foundation.
- Connect the DocsExplore our map with locations of over 350 international clinicians who are experts in diagnosing and treating NMO.
- SearchSearch our website for pages, groups, resources, articles, videos, and more.
-
- Patient Stories
- Donate